These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 34320994)
1. Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(-/-) mice. Wang Q; Wang Y; Liu S; Sha X; Song X; Dai Y; Zhao M; Cai L; Xu K; Li J J Nanobiotechnology; 2021 Jul; 19(1):222. PubMed ID: 34320994 [TBL] [Abstract][Full Text] [Related]
2. Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching. Ma S; Motevalli SM; Chen J; Xu MQ; Wang Y; Feng J; Qiu Y; Han D; Fan M; Ding M; Fan L; Guo W; Liang XJ; Cao F Theranostics; 2018; 8(13):3693-3706. PubMed ID: 30026877 [TBL] [Abstract][Full Text] [Related]
3. WISP1 alleviates lipid deposition in macrophages via the PPARγ/CD36 pathway in the plaque formation of atherosclerosis. Liu D; Wang X; Zhang M; Tian J; Liu M; Jin T; Pan J; Gao M; An F J Cell Mol Med; 2020 Oct; 24(20):11729-11741. PubMed ID: 32851768 [TBL] [Abstract][Full Text] [Related]
4. Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE Cheng XL; Ding F; Wang DP; Zhou L; Cao JM Peptides; 2019 Nov; 121():170122. PubMed ID: 31386895 [TBL] [Abstract][Full Text] [Related]
5. Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome. Lu T; Wen S; Cui Y; Ju SH; Li KC; Teng GJ Int J Cardiovasc Imaging; 2014 Jan; 30(1):221-31. PubMed ID: 24170262 [TBL] [Abstract][Full Text] [Related]
6. Targeting the KCa3.1 channel suppresses diabetes-associated atherosclerosis via the STAT3/CD36 axis. Jiang XX; Bian W; Zhu YR; Wang Z; Ye P; Gu Y; Zhang H; Zuo G; Li X; Zhu L; Liu Z; Sun C; Chen SL; Zhang DM Diabetes Res Clin Pract; 2022 Mar; 185():109776. PubMed ID: 35149165 [TBL] [Abstract][Full Text] [Related]
7. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice. Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554 [TBL] [Abstract][Full Text] [Related]
8. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway. Geng J; Yang C; Wang B; Zhang X; Hu T; Gu Y; Li J Biomed Pharmacother; 2018 Jan; 97():941-947. PubMed ID: 29136772 [TBL] [Abstract][Full Text] [Related]
9. Structures and anti-atherosclerotic effects of 1,6-α-glucans from Fructus Corni. Zhang XW; Sui Y; Liu XX; Fu CY; Qiao YH; Liu WJ; Li ZZ; Li XQ; Cao W Int J Biol Macromol; 2020 Oct; 161():1346-1357. PubMed ID: 32784023 [TBL] [Abstract][Full Text] [Related]
11. Elimination of Ox-LDL through the liver inhibits advanced atherosclerotic plaque progression. Wang Z; Guo X; Zhang Q; Du G; Zeng Z; Zheng C; Wei Y Int J Med Sci; 2021; 18(16):3652-3664. PubMed ID: 34790037 [No Abstract] [Full Text] [Related]
12. Macrophage iron retention aggravates atherosclerosis: Evidence for the role of autocrine formation of hepcidin in plaque macrophages. Xiao L; Luo G; Guo X; Jiang C; Zeng H; Zhou F; Li Y; Yu J; Yao P Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158531. PubMed ID: 31666189 [TBL] [Abstract][Full Text] [Related]
13. Hesperidin blocks varenicline-aggravated atherosclerotic plaque formation in apolipoprotein E knockout mice by downregulating net uptake of oxidized low-density lipoprotein in macrophages. Koga M; Kanaoka Y; Inada K; Omine S; Kataoka Y; Yamauchi A J Pharmacol Sci; 2020 Jun; 143(2):106-111. PubMed ID: 32173266 [TBL] [Abstract][Full Text] [Related]
14. Chlorogenic acid protects against atherosclerosis in ApoE-/- mice and promotes cholesterol efflux from RAW264.7 macrophages. Wu C; Luan H; Zhang X; Wang S; Zhang X; Sun X; Guo P PLoS One; 2014; 9(9):e95452. PubMed ID: 25187964 [TBL] [Abstract][Full Text] [Related]
15. Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α Zhang Y; Shi X; Han J; Peng W; Fang Z; Zhou Y; Xu X; Lin J; Xiao F; Zhao L; Lin Y Drug Des Devel Ther; 2021; 15():803-812. PubMed ID: 33654384 [TBL] [Abstract][Full Text] [Related]
16. Amorphous silica nanoparticles accelerated atherosclerotic lesion progression in ApoE Ma R; Qi Y; Zhao X; Li X; Sun X; Niu P; Li Y; Guo C; Chen R; Sun Z Part Fibre Toxicol; 2020 Oct; 17(1):50. PubMed ID: 33008402 [TBL] [Abstract][Full Text] [Related]
17. Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner. Bao Y; Wang L; Xu Y; Yang Y; Wang L; Si S; Cho S; Hong B Atherosclerosis; 2012 Jul; 223(1):152-9. PubMed ID: 22658257 [TBL] [Abstract][Full Text] [Related]
18. Fang S; Sun S; Cai H; Zou X; Wang S; Hao X; Wan X; Tian J; Li Z; He Z; Huang W; Liang C; Zhang Z; Yang L; Tian J; Yu B; Sun B Theranostics; 2021; 11(19):9358-9375. PubMed ID: 34646375 [No Abstract] [Full Text] [Related]
19. Non-Lethal Sonodynamic Therapy Inhibits Atherosclerotic Plaque Progression in ApoE-/- Mice and Attenuates ox-LDL-mediated Macrophage Impairment by Inducing Heme Oxygenase-1. Wang Y; Wang W; Xu H; Sun Y; Sun J; Jiang Y; Yao J; Tian Y Cell Physiol Biochem; 2017; 41(6):2432-2446. PubMed ID: 28468003 [TBL] [Abstract][Full Text] [Related]
20. SMTP-44D Inhibits Atherosclerotic Plaque Formation in Apolipoprotein-E Null Mice Partly by Suppressing the AGEs-RAGE Axis. Terasaki M; Shibata K; Mori Y; Saito T; Matsui T; Ohara M; Fukui T; Hasumi K; Higashimoto Y; Nobe K; Yamagishi SI Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]